Clear air

93%

growth operating revenue growth in hospital product group (products used in acute and chronic respiratory care and surgery) over first half of the previous financial year to $681m.

5%

revenue growth in homecare product group (products used in treatment of obstructive sleep apnea and nasal high flow therapy) to $226.2m.